|
1.
|
Occhipinti K and Smith JW: Irritable bowel
syndrome: a review and update. Clin Colon Rectal Surg. 25:46–52.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Lackner JM, Gudleski GD, Dimuro J, Keefer
L and Brenner DM: Psychosocial predictors of self-reported fatigue
in patients with moderate to severe irritable bowel syndrome. Behav
Res Ther. 51:323–331. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Stasi C, Rosselli M, Bellini M, Laffi G
and Milani S: Altered neuro-endocrine-immune pathways in the
irritable bowel syndrome: the top-down and the bottom-up model. J
Gastroenterol. 47:1177–85. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Gonsalkorale WM, Perrey C, Pravica V,
Whorwell PJ and Hutchinson IV: Interleukin 10 genotypes in
irritable bowel syndrome: evidence for an inflammatory component.
Gut. 52:91–93. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Chan J, Gonsalkorale W and Perrey M: IL-10
and TGF-beta genotype in irritable bowel syndrome: evidence to
support an inflammatory component? Gastroenterology. 118:A11912000.
View Article : Google Scholar
|
|
6.
|
Longstreth GF, Thompson WG, Chey WD,
Houghton LA, Mearin F and Spiller RC: Functional bowel disorders.
Gastroenterology. 130:1480–1419. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Fukudo S: Role of corticotrophin-releasing
hormone in irritable bowel syndrome and intestinal inflammation. J
Gastroenterol. 42:48–51. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Spiller R and Campbell E: Post-infectious
irritable bowel syndrome. Curr Opin Gastroenterol. 22:13–17. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Wouters MM and Boeckxstaens GE:
Neuroimmune mechanisms in functional bowel disorders. Neth J Med.
69:55–61. 2011.PubMed/NCBI
|
|
10.
|
Camilleri M: Evolving concepts of the
pathogenesis of irritable bowel syndrome: to treat the brain or the
gut? J Pediatr Gastroenterol Nutr. 48(Suppl 2): S46–S48. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Sugaya N and Nomura S: Relationship
between cognitive appraisals of symptoms and negative mood for
subtypes of irritable bowel syndrome. Biopsychosoc Med. 2:92008.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Nicholl BI, Halder SL, Macfarlane GJ, et
al: Psychosocial risk markers for new onset irritable bowel
syndrome - results of a large prospective population based study.
Pain. 137:147–155. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Camilleri M and Fealy RD: Idiopathic
autonomic denervation in eight patients presenting with functional
gastrointestinal disease: A causal association? Dig Dis Sci.
35:609–616. 1990. View Article : Google Scholar
|
|
14.
|
Schiepers OJ, Wichers MC and Maes M:
Cytokines and major depression. Prog Neuropsychopharmacol Biol
Psychiatry. 29:201–217. 2005. View Article : Google Scholar
|
|
15.
|
Smulevich AB, Rappoport SI, Syrkin AL, et
al: Visceral neuroses: clinical approaches to the problem. Zh
Nevrol Psikhiatr Im S S Korsakova. 102:15–21. 2002.(In
Russian).
|
|
16.
|
Chadwick VS, Chen W, Shu D, et al:
Activation of the mucosal immune system in irritable bowel
syndrome. Gastroenterology. 122:1178–1783. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Li Y, Wang Y, Zuo X, et al: Visceral
perception thresholds after rectal thermal and pressure stimuli in
irritable bowel syndrome patients. J Gastroenterol Hepatol.
19:187–191. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Smart HL and Atkinson M: Abnormal vagal
function in irritable bowel syndrome. Lancet. 2:475–478. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Dinan TG, Quigley EM, Ahmed SM, et al:
Hypothalamic-pituitary-gut axis dysregulation in irritable bowel
syndrome: plasma cytokines as a potential biomarker?
Gastroenterology. 130:304–311. 2006. View Article : Google Scholar
|
|
20.
|
Drossman DA: The functional
gastrointestinal disorders and the Rome III process.
Gastroenterology. 130:1377–1390. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Heller F, Florian P, Bojarski C, et al:
Interleukin-13 is the key effector Th2 cytokine in ulcerative
colitis that affects epithelial tight junctions, apoptosis, and
cell restitution. Gastroenterology. 129:550–564. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Liebregts T, Adam B, Bredack C, et al:
Immune activation in patients with irritable bowel syndrome.
Gastroenterology. 132:913–920. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Akbar A, Yiangou Y, Facer P, Walters JR,
Anand P and Ghosh S: Increased capsaicin receptor TRPV1-expressing
sensory fibres in irritable bowel syndrome and their correlation
with abdominal pain. Gut. 57:923–929. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Binimelis J, Webb SM and Monés J:
Somatostatin and the irritable bowel syndrome. Lancet. 2:15331987.
View Article : Google Scholar
|
